CY1116851T1 - USE OF CLOMBETAZOLI MEDICINAL PRODUCT COMPOSITION FOR TREATMENT OF SPORTS - Google Patents

USE OF CLOMBETAZOLI MEDICINAL PRODUCT COMPOSITION FOR TREATMENT OF SPORTS

Info

Publication number
CY1116851T1
CY1116851T1 CY20151100724T CY151100724T CY1116851T1 CY 1116851 T1 CY1116851 T1 CY 1116851T1 CY 20151100724 T CY20151100724 T CY 20151100724T CY 151100724 T CY151100724 T CY 151100724T CY 1116851 T1 CY1116851 T1 CY 1116851T1
Authority
CY
Cyprus
Prior art keywords
clombetazoli
sports
treatment
product composition
medicinal product
Prior art date
Application number
CY20151100724T
Other languages
Greek (el)
Inventor
Gordon J Dow
Daniel M Stewart
Original Assignee
Dow Pharmaceutical Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20060750845 external-priority patent/EP1885373B1/en
Application filed by Dow Pharmaceutical Sciences filed Critical Dow Pharmaceutical Sciences
Publication of CY1116851T1 publication Critical patent/CY1116851T1/en

Links

Abstract

Η παρούσα εφεύρεση δίδει μία μέθοδο για τη θεραπευτική αγωγή της ψωρίασης δια ψεκασμού επί του δέρματος, όπου εμφανίζεται η ψωρίαση, καθημερινά, επί τουλάχιστον 4 βδομάδες μίας φαρμακευτικής σύνθεσης η οποία περιέχει μία αποτελεσματική ποσότητα προπιονικής κλομπεταζόλης. Μία προτιμώμενη φαρμακευτική σύνθεση η οποία περιέχει προπιονική κλομπεταζόλη, αιθυλαλκοόλη, μυριστικό ισοπροπυλεστέρα και ανιονικό επιφανειοδραστικό.The present invention provides a method for treating skin psoriasis by spraying, where psoriasis occurs daily, for at least 4 weeks in a pharmaceutical composition containing an effective amount of clobetazole propionate. A preferred pharmaceutical composition comprising clobetazole propionate, ethyl alcohol, isopropyl myristate and anionic surfactant.

CY20151100724T 2005-04-25 2015-08-19 USE OF CLOMBETAZOLI MEDICINAL PRODUCT COMPOSITION FOR TREATMENT OF SPORTS CY1116851T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67494605A 2005-04-25 2005-04-25
EP20060750845 EP1885373B1 (en) 2005-04-25 2006-04-20 Use of a clobetasol spray formulation to treat psoriasis

Publications (1)

Publication Number Publication Date
CY1116851T1 true CY1116851T1 (en) 2017-04-05

Family

ID=58487008

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100724T CY1116851T1 (en) 2005-04-25 2015-08-19 USE OF CLOMBETAZOLI MEDICINAL PRODUCT COMPOSITION FOR TREATMENT OF SPORTS

Country Status (1)

Country Link
CY (1) CY1116851T1 (en)

Similar Documents

Publication Publication Date Title
KR102242894B1 (en) How to suppress off-flavor
HK1091151A1 (en) Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
MX2007013230A (en) Use of a clobetasol spray formulation to treatment psoriasis.
BRPI0416160A (en) antimicrobial shampoo compositions
FR2887886B1 (en) NEUTRALIZED CATIONIC POLYMER, COMPOSITION COMPRISING THE SAME AND COSMETIC TREATMENT METHOD
BR0116370A (en) Compound, pharmaceutical composition, use of a compound, and method of treating an hppar-mediated disease or condition in a patient.
ATE469674T1 (en) 5-AMINOLEVULIC ACID DERIVATIVES FOR THE TREATMENT OF ACNE
BR0313627A (en) Pharmaceutical formulations, processes for the preparation of pharmaceutical formulations and method for treating pain
TW200509956A (en) Compositions and methods for treatment of rosacea
ES2161785T3 (en) EMPLASTO FOR THE TREATMENT OF UNGULAR MICOSIS.
BRPI0407662A (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
BRPI0407181A (en) Pharmaceutical Formulation
EP2144608A4 (en) Sunscreen compositions and methods
ECSP034518A (en) NEW RETINOIDS FOR THE EMPHYSEMA TREATMENT
BRPI0607684A2 (en) pharmaceutical composition, method for preventing or treating depression or anxiety disorders, and use of -n- [2- (1,6,7,8-tetrahydro-2h-indene [5,4-b] furan- 8-yl) ethyl] propionamide
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
BR0311903A (en) Treatment for depression and anxiety by combining an iv pde inhibitor and an antidepressant or anxiolytic agent
RS50148B (en) Use of docetaxel for treating hepatocellular carcinoma
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
DE60000286T2 (en) SOYA EXTRACTS CONTAINING LIPIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AND COSMETIC COMPOSITION
BR0116653A (en) Medicinal product containing a polyamine as active substance
PA8549401A1 (en) COMPLEX THAT INCLUDES INHIBITING FACTOR OF OSTEOCLASTOGENESIS AND POLISACARIDO
PL373528A1 (en) Medicine for preventing and treating bromidrosis
CY1116851T1 (en) USE OF CLOMBETAZOLI MEDICINAL PRODUCT COMPOSITION FOR TREATMENT OF SPORTS
DE602006005637D1 (en) ENTPIGMENTIZING BZW. CREAMING COSMETICS COMPOSITION CONTAINING AT LEAST ONE OXAZOLINE AS AN ACTIVE SUBSTANCE